Tremelimumab: observed
15 studies: patients on it are followed, or it is given outside a trial. Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.
- Immune-Related Adverse Events and Clinical Outcomes of First-Line Immunotherapy in Egyptian Patients With Unresectable Hepatocellular CarcinomaNot yet recruitingNCT07904494Report a problem
- Real-world Insight Into Systemic Therapies for HCC: Single-center StudyRecruitingNCT07814014Report a problem
- MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.RecruitingNCT07607769Report a problem
- Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular CarcinomaRecruitingNCT06806579Report a problem
- Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and DurvalumabRecruitingNCT06796114Not applicableReport a problem
- NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic AlterationsRecruitingNCT06494540Report a problem
- Observational Study Protocol: LIVER-RRecruitingNCT06252753Report a problem
- Microbiome Immunotherapy Toxicity and Response EvaluationRecruitingNCT04107168Report a problem
- Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung CancerCompletedNCT02154490Results postedReport a problem
- Comparison of Atezolizumab/Bevacizumab Versus Durvalumab/Tremelimumab (STRIDE) Protocols in Locally Advanced or Metastatic Hepatocellular Carcinoma Among Patients in SohagActive, not recruitingNCT07669597Report a problem
- An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With SurgeryActive, not recruitingNCT06117891Report a problem
- EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance DatabaseCompletedNCT05934214Report a problem
- Himalaya Early Access ProgramApproved for marketingNCT05345678Report a problem
- Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn DiseaseTerminatedNCT00897312Report a problem
- Treatment Use Study for Advanced Melanoma.No longer availableNCT00584493Report a problem